The Latest In Oxaloacetate Research

New Long COVID Clinical Trial Shows Oxaloacetate CFS Significantly Improves Cognitive Function and Reduces Symptom Burden in Long COVID Patients

New Long COVID Clinical Trial Shows Oxaloacetat...

August 2025 — SAN DIEGO, CA — A new randomized, double blind, controlled clinical trial published in Frontiers in Neuroscience reveals promising results for Oxaloacetate CFS, a medical food for...

New Long COVID Clinical Trial Shows Oxaloacetat...

August 2025 — SAN DIEGO, CA — A new randomized, double blind, controlled clinical trial published in Frontiers in Neuroscience reveals promising results for Oxaloacetate CFS, a medical food for...

FDA Allows Oxaloacetate CFS Structure/Function Claim for ME/CFS

FDA Allows Oxaloacetate CFS Structure/Function ...

Based on the results of peer-reviewed clinical trials, doctor and patient reports and the existing body of research investigating Oxaloacetate, the U.S. Food and Drug Administration has allowed the following...

FDA Allows Oxaloacetate CFS Structure/Function ...

Based on the results of peer-reviewed clinical trials, doctor and patient reports and the existing body of research investigating Oxaloacetate, the U.S. Food and Drug Administration has allowed the following...

International ME/CFS Conference 2025 Features Oxaloacetate CFS Clinical Data

International ME/CFS Conference 2025 Features O...

At the International ME/CFS Conference 2025 in Berlin, Oxaloacetate CFS Chief Science Officer Alan Cash, a global leader of oxaloacetate research—delivered a compelling keynote on the potential of oxaloacetate medical...

International ME/CFS Conference 2025 Features O...

At the International ME/CFS Conference 2025 in Berlin, Oxaloacetate CFS Chief Science Officer Alan Cash, a global leader of oxaloacetate research—delivered a compelling keynote on the potential of oxaloacetate medical...

Alan Cash of Terra Biological to Present Breakthrough Oxaloacetate Research at 2025 International ME/CFS Conference

Alan Cash of Terra Biological to Present Breakt...

The 2025 International ME/CFS Conference, hosted by the ME/CFS Research Foundation, is set to feature a pivotal presentation by Alan Cash, Chief Science Officer of Terra Biological LLC. Scheduled for May...

Alan Cash of Terra Biological to Present Breakt...

The 2025 International ME/CFS Conference, hosted by the ME/CFS Research Foundation, is set to feature a pivotal presentation by Alan Cash, Chief Science Officer of Terra Biological LLC. Scheduled for May...

International ME/CFS Conference 2025 to Spotlight Advances in Treatment and Research for Chronic Fatigue and Post-COVID Syndromes

International ME/CFS Conference 2025 to Spotlig...

Berlin, Germany — Medical professionals, researchers, and global experts will converge—virtually and in-person—on May 12-13, 2025, for the International ME/CFS Conference, a two-day hybrid event dedicated to the latest developments...

International ME/CFS Conference 2025 to Spotlig...

Berlin, Germany — Medical professionals, researchers, and global experts will converge—virtually and in-person—on May 12-13, 2025, for the International ME/CFS Conference, a two-day hybrid event dedicated to the latest developments...

The Enhanced Responder Phenomenon with ME/CFS and Oxaloacetate Therapy

The Enhanced Responder Phenomenon with ME/CFS a...

More than 17 million people worldwide have ME/CFS and chronic fatigue. As medical care scrambles to find more effective treatments, the Bateman Horne Center finds that Oxaloacetate Therapy, under the...

The Enhanced Responder Phenomenon with ME/CFS a...

More than 17 million people worldwide have ME/CFS and chronic fatigue. As medical care scrambles to find more effective treatments, the Bateman Horne Center finds that Oxaloacetate Therapy, under the...